or Try an Advanced Search...

    Technical Analysis for ARMP - Armata Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    C 2.68 -1.47% -0.04
    ARMP closed down 1.47 percent on Thursday, November 14, 2024, on 27 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical ARMP trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Above Upper BB Strength 0.00%
    200 DMA Resistance Bearish -1.47%
    Volume Surge Other -1.47%
    Upper Bollinger Band Walk Strength -1.47%
    Earnings Movers Other -1.47%
    Above Upper BB Strength -1.47%
    Gapped Up Strength -1.47%
    Crossed Above 20 DMA Bullish -2.55%
    Older End-of-Day Signals for ARMP ...

       Recent Intraday Alerts

    Alert Time
    Reversed from Up about 12 hours ago
    Possible NR7 about 12 hours ago
    Possible Inside Day about 12 hours ago
    200 DMA Resistance about 14 hours ago
    Up 5% about 14 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ARMP Chart by TradingView
    Basic chart:

    Profile

    Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Armata's lead product candidate, AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. The Company is also developing and advancing a broad pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa, leveraging its proprietary phage-specific GMP manufacturing capabilities.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Antibiotics Bacteria Pseudomonas Staphylococcus Aureus Gram Negative Bacteria Manufacturing Capabilities Pathogenic Bacteria Bacteriophage Drug Resistance Multiple Drug Resistance Pseudomonas Aeruginosa

    Is ARMP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 12 Armata Pharmaceuticals (ARMP) Upgraded to Buy: What Does It Mean for the Stock?
    Sep 5 Armata Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
    Aug 26 Armata Pharmaceuticals Announces Presentation at the 2024 Military Health System Research Symposium
    Aug 15 Armata Pharmaceuticals Announces Appointment of Life Sciences Accounting and Finance Veteran David House as SVP of Finance and Principal Financial Officer
    Aug 14 Armata Pharmaceuticals GAAP EPS of -$0.25
    Aug 13 Armata Pharmaceuticals Announces Second Quarter 2024 Results and Provides Corporate Update
    Jul 30 Armata Pharmaceuticals Receives $5.25 Million of Additional Non-Dilutive Grant Funding from the U.S. Department of Defense to Support Ongoing diSArm Clinical Trial of AP-SA02
    Jul 11 Armata Pharmaceuticals Announces Completion of Enrollment of Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection
    Jul 10 Armata Pharmaceuticals Announces Presentation at Viruses of Microbes 2024
    See more ARMP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.48
    52 Week Low 1.93
    Average Volume 6,613
    200-Day Moving Average 2.83
    50-Day Moving Average 2.34
    20-Day Moving Average 2.38
    10-Day Moving Average 2.42
    Average True Range 0.16
    RSI (14) 64.54
    ADX 38.06
    +DI 30.63
    -DI 11.84
    Chandelier Exit (Long, 3 ATRs) 2.49
    Chandelier Exit (Short, 3 ATRs) 2.67
    Upper Bollinger Bands 2.68
    Lower Bollinger Band 2.08
    Percent B (%b) 1.0
    BandWidth 25.11
    MACD Line 0.06
    MACD Signal Line 0.01
    MACD Histogram 0.0464
    Fundamentals Value
    Market Cap 96.87 Million
    Num Shares 36.1 Million
    EPS -1.65
    Price-to-Earnings (P/E) Ratio -1.62
    Price-to-Sales 35.33
    Price-to-Book 4.06
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.81
    Resistance 3 (R3) 2.82 2.79 2.79
    Resistance 2 (R2) 2.79 2.76 2.79 2.78
    Resistance 1 (R1) 2.74 2.74 2.72 2.72 2.77
    Pivot Point 2.71 2.71 2.70 2.70 2.71
    Support 1 (S1) 2.65 2.68 2.64 2.64 2.59
    Support 2 (S2) 2.62 2.66 2.62 2.58
    Support 3 (S3) 2.57 2.62 2.57
    Support 4 (S4) 2.55